What is the limit for genotoxic impurity?
The acceptable limits for daily intake of genotoxic impurities are 5, 10, 20, and 60µg/day for a duration of exposure of 6-12 months, 3-6 months, 1-3 months, and less than 1 month, respectively. For a single dose an intake of up to 120 µg is acceptable.
How do you identify genotoxic impurities?
Guided by existing genotoxicity data or the presence of structural alerts, potential genotoxic impurities should be identified. When a potential impurity contains structural alerts, additional genotoxicity testing of the impurity, typically in a bacterial reverse mutation assay, should be considered (Dobo et al.
What is TTC level?
The Threshold of Toxicological Concern (TTC) is a level of human intake or exposure that is considered to be of negligible risk, despite the absence of chemical-specific toxicity data.
What are the genotoxic impurities in API?
Class 1 impurities are genotoxic (i.e., mutagenic) and carcinogenic. These impurities represent the most serious risk, and the default preference is to eliminate them by modifying the process. If this is not possible, the TTC limit can be employed as a last resort.
How are genotoxic impurities formed?
Genotoxic impurities can get incorporated through various sources, mostly starting material used in drug synthesis and its impurities in the form of genotoxic intermediate or process related by-products in the synthesis process.
What is purge factor?
purge factor is defined as the level of an impurity at an upstream point in a process. divided by the level of an impurity at a downstream point in a process. • Purge factors may be measured or predicted. 1.
What is toxicity threshold?
The Threshold of Toxicological Concern (TTC) is a concept that refers to the establishment of a level of exposure for all chemicals, whether or not there are chemical-specific toxicity data, below which there would be no appreciable risk to human health.
What are the quality guidelines as per ICH?
Q1A – Q1F Stability. Q1A(R2)Stability Testing of New Drug Substances and Products.
What is purge ratio?
A purge ratio is the ratio of the volume of hydrogen in the purged gas to the volume of hydrogen in the makeup gas. Purging is required to prevent the buildup of inert gases and light hydrocarbons in the recycle gas. The quantity of purge directly influences the purity of the hydrogen in the recycle gas.
What is fate and purge study?
Drug substances produced by chemical syntheses contain impurities (organic, inorganic, elemental, or residual solvents) which must be controlled in order to ensure the desired product quality.
What is threshold quantity?
Threshold quantity refers to the amount of a toxic substance that, if released, could cause serious danger as a result of exposures of 1 hour or less. Threshold quantities should be estimated for the facility using engineering judgment and available dispersion modeling techniques.
What is toxicity curve?
Unit toxicity – Amount of response (yield decrease) per unit of toxicant after the threshold of toxicity is passed. The slope of the curve in the toxic zone is an indication of the degree or unit toxicity of the toxicant, e.g., steeper the curve the greater the toxicity of the applied toxicant.
What is ICH Q10 guidelines?
ICH Q10 is a model. for a pharmaceutical quality system that can be implemented throughout the different stages of a product lifecycle. Much of the content of ICH Q10 applicable to manufacturing sites is currently specified by regional GMP requirements.
What is the FDA guidance on genotoxic and carcinogenic impurities?
The FDA guidance provides specific recommendations regarding the safety qualification of impurities with known or suspected genotoxic or carcinogenic potential. The guidance describes a variety of ways to characterize and reduce the potential cancer risk with patient exposure to genotoxins and carcinogenic impurities.
What is the global guideline for genotoxicity testing for pharmaceutical products?
The global guideline for genotoxicity testing for pharmaceutical products is the ICH Guideline S2 (R1)1which bears the title Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use. It combines the two guidances previously published as S2A: Specific Aspects for Regulatory Genotoxicity Tests for Pharmaceuticals
Are genotoxic impurities covered by Q3A and q3b guidelines?
The SWP committee felt that impurities with genotoxic potential were a special case not covered by the Q3A and Q3B guidances. Therefore, the intent was to close a gap in the ICH guidelines on the control of impurities, and particularly those potential impurities that are expected to be unusually potent, such as potential genotoxic impurities.
What is the range of detection limits for genotoxic impurities?
Analysis of genotoxic impurities can be very challenging because they must be controlled at levels significantly lower than 0.01–0.03 %. Ideally, the analytical procedure should allow detection limits in the range of 1 to 5 ppm (0.0001–0.0005 % w/w).